New decision aid for patients considering adjuvant therapy
Adjuvant therapy is now available as a treatment option in most provinces for patients with localized kidney cancer who have an intermediate to high risk of recurrence. Deciding whether adjuvant therapy is right for you is not easy. To help patients make an informed decision about this treatment option, Kidney Cancer Canada has collaborated with healthcare professionals with Dr. Kristen McAlpine, uro-oncologist as lead author to develop an adjuvant therapy decision aid.
See decision aid here